© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
July 27th 2021, 2:09pm
Kidney cancer expert, Dr Thomas E. Hutson, shares insight on managing adverse events resulting from combination therapy in RCC.
July 26th 2021, 6:00pm
An expert discusses the most common reasons his patients ask him about medical marijuana.
July 21st 2021, 5:48pm
Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.
July 21st 2021, 4:05pm
Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.
July 20th 2021, 9:00pm
The vaccine immune response monitoring platform can identify weak responses in patients with cancer and help determine the potential need for a booster shot.
July 20th 2021, 4:45pm
Thomas E. Hutson, DO, PharmD, discusses his approach to determining the optimal initial therapy for a patient with RCC.
July 20th 2021, 4:40pm
Urologic oncology expert, Dr Thomas E. Hutson, reviews additional agents and clinical trials in the pipeline for the treatment of RCC.
July 14th 2021, 9:30pm
View the full CURE® Educated Patient® Webinar: Gastrointestinal Stromal Tumor (GIST).
July 14th 2021, 2:09pm
Cancer patients, Deborah and George, reflect on their emotions while waiting to receive back results from biomarker testing and explain what it was like processing the information delivered by their test results as presented by their oncologists.
July 14th 2021, 2:01pm
George Labonte explains what it was like receiving a diagnosis of medullary thyroid cancer and describes his experience being recommended for biomarker testing and concerns surrounding testing for germline mutations.
3 Ways to Get Cancer Off Your Back
Pregnant Women With Previous or Current Cancer Diagnoses May Experience More Complications During Delivery
Navigating the Unknown of Rare Cancers
Playing With House Money: Defying Cancer Odds